Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04020757 · ClinicalTrials.gov registry record · Phase 2
H+ Mobilization With Dialysate Bicarbonate Variation
A Phase 2 study, sponsored by Tufts Medical Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 13
- Enrollment target
NCT04020757 is a Phase 2 study that was terminated before completion, run by Tufts Medical Center. The registered enrollment target is 13 participants.
The verdict
NCT04020757, a Phase 2 study, was terminated before completion, sponsored by Tufts Medical Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 13 participants
- Enrollment target
Study Summary
The aims of the proposed studies are first to delineate the physiological response of End Stage Kidney Disease (ESKD) patients to exposure to a bath \[HCO3-\] of 35 mEq/L and an \[acetate\] of 4 mEq/L, and second, to determine whether reducing bath \[HCO3-\] will have the expected effect of decreasing or abolishing stimulation of organic acid production. A secondary endpoint will be whether the patients tolerate such a reduction and its impact on pre-dialysis blood \[HCO3-\]. If the outcome is positive in both regards, future studies will measure well-being and outcomes with reduced bath \[HCO3-\].
Interventions
- DEVICE variation in dialysis bicarbonate
- DIETARY_SUPPLEMENT Zone Perfect bar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2019-06-12 |
| Est. Completion | 2019-11-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04020757
The ClinicalTrials.gov registry entry for NCT04020757 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which variation in dialysis bicarbonate is the first listed.
NCT04020757 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04020757 about?
NCT04020757 is a clinical study titled "H+ Mobilization With Dialysate Bicarbonate Variation". The aims of the proposed studies are first to delineate the physiological response of End Stage Kidney Disease (ESKD) patients to exposure to a bath \[HCO3-\] of 35 mEq/L and an \[acetate\] of 4 mEq/L, and second, to determine whether reducing bath \[HCO3-\] will have the expected effect of decreasi...
What is the current status of trial NCT04020757?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 13 participants. The study started on 2019-06-12. Estimated completion is 2019-11-30.
What interventions are being tested in trial NCT04020757?
The interventions under investigation include: variation in dialysis bicarbonate (DEVICE), Zone Perfect bar (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04020757?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.